Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Greta
Greta Cof, Medvode SL
| Patent application number | Description | Published |
|---|---|---|
| 20100183714 | GASTRORESISTANT PHARMACEUTICAL DOSAGE FORM COMPRISING N-(2-(2- PHTHALIMIDOETHOXY)-ACETYL)-L-ALANYL-D-GLUTAMIC ACID (LK-423) - The present invention relates to the pharmaceutical dosage forms which enable a controlled and/or a targeted delivery of an active substance to the selected regions of gastrointestinal tract of humans or animals. The pharmaceutical dosage forms preferably comprises the active substance N-(2(2-phthalimidoethoxy)-acetyl)-L-alanyl-D-glutamic acid (designated as LK 423). Methods of treatment of chronic inflammatory diseases of gastrointestinal tract of humans and/or animals by using the pharmaceutical dosage forms of the invention are disclosed. | 07-22-2010 |
Greta Maakannas, Helsinki FI
| Patent application number | Description | Published |
|---|---|---|
| 20100157545 | INTERFERENCE SHIELDED ELECTRONICS MODULE AND METHOD FOR PROVIDING THE SAME - An interference shielded, for example a RFI and/or EMI shielded, for an electronics module which forms a contact with at least one edge zone of a circuit board, is provided. The contact functions in the electronics module as a ground. The circuit board includes an outermost electrically conductive layer providing the interference shield of the electronics module; at least one circuit card layer unit comprising electronics components and a wiring pattern embedded into a filling material of the circuit board layer; and encapsulating activation material layer. The activation material layer is advantageously a substrate layer or a resin layer, and which overlays above the topmost circuit board layer, and which is arranged into a space between the outermost layer and topmost circuit board layer to be therein conformingly against the inner surface of the outermost layer for isolating the electronic components and the wiring pattern from outermost layer. | 06-24-2010 |
Greta Sterimbaum, Rishon-Lezion IL
| Patent application number | Description | Published |
|---|---|---|
| 20080269488 | Novel crystalline forms of gatifloxacin - Provided are two novel crystalline forms of gatifloxacin, denominated form O and form V, and methods for their preparation. | 10-30-2008 |
| 20090234125 | Amorphous retapamulin and processes for preparation thereof - An amorphous form of Retapamulin, preferably in powder form, and processes for preparation thereof, are provided. Amorphous Retapamulin of the present invention can contain less than about 10 percent crystallinity, preferably less than about 5 percent crystallinity. Pharmaceutical compositions comprising amorphous Retapamulin are also provided. | 09-17-2009 |
| 20090247569 | Process for Preparing Clopidogrel Bisulphate - Provided are processes for the preparation of clopidogrel bisulphate Form I. | 10-01-2009 |
| 20100076195 | PURIFICATION OF MONTELUKAST - The present invention provides methods of purifying montelukast, a new isolated impurity of montelukast, method for its isolation, and method of using montelukast impurity as a reference marker and a reference standard. | 03-25-2010 |
| 20100190812 | NILOTINIB HCL CRYSTALLINE FORMS - Crystalline forms of Nilotinib HCl are described. | 07-29-2010 |
Greta Sterimbaum, Rishon Letzhion IL
| Patent application number | Description | Published |
|---|---|---|
| 20100087525 | STEREOSELECTIVE ENZYMATIC SYNTHESIS OF (S) OR (R)-ISO-BUTYL-GLUTARIC ESTER - The present invention relates to a stereoselective enzymatic synthesis of (S) or (R)-iso-butyl-glutaric ester, an intermediate of S-Pregabalin. | 04-08-2010 |
Greta Varchi, Bologna IT
| Patent application number | Description | Published |
|---|---|---|
| 20100210721 | POLYENYLCYCLOPROPANECARBOXYLIC ESTERS WITH HIGH INSECTICIDAL ACTIVITY - Described are new insecticide compounds that are derived from 2,2-dimethyl-3-(2-methylpropenyl)cyclopropanecarboxylic acid, also known as chrysanthemic acid, insecticidal compositions that contain the compounds, methods of synthesizing the compounds and methods of eliminating harmful insects from a substrate including bringing the substrate into contact with an effective amount of one or more such compounds. | 08-19-2010 |
Greta Yorsh, Tarrytown, NY US
| Patent application number | Description | Published |
|---|---|---|
| 20110258606 | ABSTRACTION-GUIDED SYNTHESIS - Given a program P, a specification S, and an abstraction function α, verification determines whether P satisfies the specification S under the abstraction α. If not, a trace T that violate the specification is selected, and either the abstraction α is refined or a constraint that avoids the trace T is computed and added to a set of constraints. The set of constraints are used to modify the program P. | 10-20-2011 |